BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1676477)

  • 1. PUVA and cancer: a large-scale epidemiological study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Christensen OB; Andersson T; Törngren M; Molin L
    Lancet; 1991 Jul; 338(8759):91-3. PubMed ID: 1676477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
    Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
    Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
    Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS; Lunder EJ
    Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin disease and malignancy. An epidemiological study.
    Sigurgeirsson B
    Acta Derm Venereol Suppl (Stockh); 1992; 178():1-110. PubMed ID: 1288038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy.
    Park HS; Lee YS; Chun DK
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):578-80. PubMed ID: 12941100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
    Ortiz Salvador JM; Pérez-Ferriols A; Alegre de Miquel V; Saneleuterio Temporal M; Vilata Corell JJ
    Med Clin (Barc); 2019 Jun; 152(12):488-492. PubMed ID: 30503067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
    Lever LR; Farr PM
    Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.